Position in LYEL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$70,601
-$47,993 QoQ
Shares Held
5,025
-15.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. LYEL ranks #279 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in LYEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,601 | 5,025 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $118,594 | 5,912 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $130,291 | 4,233 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $16,727 | 1,030 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $18,166 | 2,055 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $63,431 | 117,905 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $84,400 | 131,877 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $178,436 | 129,303 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $71,551 | 49,347 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $106,341 | 47,687 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $146,939 | 75,742 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $284,795 | 193,739 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $513,614 | 161,514 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $983,475 | 416,727 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $939,155 | 270,650 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,514,860 | 206,666 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $208,678 | 32,006 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $210,292 | 41,642 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $367,549 | 47,487 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $39,871 | 2,694 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||